Your browser doesn't support javascript.
loading
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies.
Ferri, Clodoveo; Raimondo, Vincenzo; Gragnani, Laura; Giuggioli, Dilia; Dagna, Lorenzo; Tavoni, Antonio; Ursini, Francesco; L'Andolina, Massimo; Caso, Francesco; Ruscitti, Piero; Caminiti, Maurizio; Foti, Rosario; Riccieri, Valeria; Guiducci, Serena; Pellegrini, Roberta; Zanatta, Elisabetta; Varcasia, Giuseppe; Olivo, Domenico; Gigliotti, Pietro; Cuomo, Giovanna; Murdaca, Giuseppe; Cecchetti, Riccardo; De Angelis, Rossella; Romeo, Nicoletta; Ingegnoli, Francesca; Cozzi, Franco; Codullo, Veronica; Cavazzana, Ilaria; Colaci, Michele; Abignano, Giuseppina; De Santis, Maria; Lubrano, Ennio; Fusaro, Enrico; Spinella, Amelia; Lumetti, Federica; De Luca, Giacomo; Bellando-Randone, Silvia; Visalli, Elisa; Bosco, Ylenia Dal; Amato, Giorgio; Giannini, Daiana; Bilia, Silvia; Masini, Francesco; Pellegrino, Greta; Pigatto, Erika; Generali, Elena; Mariano, Giuseppa Pagano; Pettiti, Giorgio; Zanframundo, Giovanni; Brittelli, Raffaele.
Afiliación
  • Ferri C; Rheumatology Unit, University of Modena and Reggio Emilia, School of Medicine, Modena, Italy.
  • Raimondo V; Rheumatology Clinic 'Madonna dello Scoglio' Cotronei, Crotone, Italy.
  • Gragnani L; Rheumatology Clinic 'Madonna dello Scoglio' Cotronei, Crotone, Italy.
  • Giuggioli D; Department of Clinical Experimental Medicine, Interdepartmental Hepatology Center MASVE, University of Florence, Firenze, Italy.
  • Dagna L; Rheumatology Unit, University of Modena and Reggio Emilia, School of Medicine, Modena, Italy.
  • Tavoni A; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS H San Raffaele, Milan, Italy.
  • Ursini F; Vita-Salute San Raffaele University, Milan, Italy.
  • L'Andolina M; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Caso F; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Ruscitti P; Department of Biomedical and Neuromotor Sciences (DIBINEM), Alma Mater Studiorum University of Bologna, Bologna, Italy
  • Caminiti M; Rheumatology Outpatient Clinic, ASP- Vibo Valentia-Tropea Hospital, Italy.
  • Foti R; Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Riccieri V; Rheumatology Unit, Department of Biotechnological & Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Guiducci S; UOD Reumatologia- Grande Ospedale Metropolitano, Reggio Calabria, Italy.
  • Pellegrini R; AOU Policlinico Vittorio Emanuele, Catania, Italy.
  • Zanatta E; Rheumatology, Sapienza-University of Rome, Roma, Italy.
  • Varcasia G; Rheumatology, University of Florence, Firenze, Italy.
  • Olivo D; U.O.C. Medicina Interna 'M.Valentini" P.O. Annunziata, Cosenza, Italy.
  • Gigliotti P; Rheumatology, University of Padova, Padova, Italy.
  • Cuomo G; U.O.S. Reumatologia, Ospedale Castrovillari, Cosenza, Italy.
  • Murdaca G; Rheumatology Outpatient Clinic, San Giovanni di Dio Hospital, Crotone, Italy.
  • Cecchetti R; U.O.T. Specialistica Ambulatoriale ASP 201, Cosenza, Italy.
  • De Angelis R; University of Campania, Luigi Vanvitelli, Napoli, Italy.
  • Romeo N; Ospedale Policlinico S. Martino-University of Genova, Genova, Italy.
  • Ingegnoli F; Ospedale di Portoferraio, Livorno, Italy.
  • Cozzi F; Rheumatology Clinic, Department of Clinical & Molecular Sciences, Marche Polytechnic University, Ancona, Italy.
  • Codullo V; ASO S. Croce e Carle, Cuneo, Italy.
  • Cavazzana I; Rheumatology, University of Milano, Milano, Italy.
  • Colaci M; Ospedale "Villa Salus", Mestre, Italy.
  • Abignano G; Rheumatology, Policlinico San Matteo, Pavia, Italy.
  • De Santis M; Rheumatology, Spedali Civili di Brescia, Brescia, Italy.
  • Lubrano E; Rheumatology, University of Catania, Catania, Italy.
  • Fusaro E; AOR San Carlo di Potenza, Potenza, Italy.
  • Spinella A; Humanitas Clinical and Research Center IRCCS, Milano, Italy.
  • Lumetti F; Rheumatology, Università del Molise, Campobasso, Italy.
  • De Luca G; Rheumatology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Bellando-Randone S; Rheumatology Unit, University of Modena and Reggio Emilia, School of Medicine, Modena, Italy.
  • Visalli E; Rheumatology Unit, University of Modena and Reggio Emilia, School of Medicine, Modena, Italy.
  • Bosco YD; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS H San Raffaele, Milan, Italy.
  • Amato G; Vita-Salute San Raffaele University, Milan, Italy.
  • Giannini D; Rheumatology, University of Florence, Firenze, Italy.
  • Bilia S; AOU Policlinico Vittorio Emanuele, Catania, Italy.
  • Masini F; AOU Policlinico Vittorio Emanuele, Catania, Italy.
  • Pellegrino G; AOU Policlinico Vittorio Emanuele, Catania, Italy.
  • Pigatto E; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Generali E; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  • Mariano GP; University of Campania, Luigi Vanvitelli, Napoli, Italy.
  • Pettiti G; Rheumatology, Sapienza-University of Rome, Roma, Italy.
  • Zanframundo G; Ospedale "Villa Salus", Mestre, Italy.
  • Brittelli R; Humanitas Clinical and Research Center IRCCS, Milano, Italy.
Curr Pharm Des ; 28(24): 2022-2028, 2022.
Article en En | MEDLINE | ID: mdl-35726427

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Autoinmunes / Enfermedades Pulmonares Intersticiales / Antirreumáticos / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Curr Pharm Des Asunto de la revista: FARMACIA Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Autoinmunes / Enfermedades Pulmonares Intersticiales / Antirreumáticos / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Curr Pharm Des Asunto de la revista: FARMACIA Año: 2022 Tipo del documento: Article País de afiliación: Italia